Department of Anorectal Surgery, The First Hospital of China Medical University, Shenyang, 110001, People's Republic of China.
Int J Colorectal Dis. 2019 Apr;34(4):681-689. doi: 10.1007/s00384-019-03241-1. Epub 2019 Jan 24.
We aimed to explore whether the preoperative prognostic nutritional index (PNI) could be an indicator of prognostic outcomes in colorectal cancer (CRC) patients.
A systematic review and meta-analysis was conducted using the PubMed, Embase, and Web of Science databases. All original comparative studies published in English that were related to a high PNI versus a low PNI in CRC patients were included.
A total of 10 studies involving 6372 patients were included in our meta-analysis. Our overall analysis indicated that the low-PNI group had a significantly reduced overall survival (OS) (HR = 1.87, 95% CI = 1.45-2.42, P < 0.01), cancer-specific survival (HR = 1.53, 95% CI = 1.07-2.19, P = 0.02), and disease-free survival (HR = 1.67, 95% CI = 1.23-2.26, P < 0.01) compared with the high-PNI group. Furthermore, our subgroup results indicated that a high PNI could be a significant indicator of improved OS in TNM stage II (HR = 1.93, 95% CI = 1.29-2.90, P < 0.01) and III (HR = 1.71, 95% CI = 1.25-2.34, P < 0.01), and a similar trend in TNM stage I or IV could also be observed though without statistical significance. Regarding postoperative complications, our pooled results indicated that the low-PNI group had a significantly increased incidence of total and severe postoperative complications.
Our findings indicated that CRC patients with a preoperative high PNI had a significantly improved OS. However, almost only Asian CRC patients were included based on current issue.
本研究旨在探讨术前预后营养指数(PNI)是否可作为结直肠癌(CRC)患者预后结局的指标。
通过PubMed、Embase 和 Web of Science 数据库进行系统回顾和荟萃分析。所有纳入的原始比较研究均为英文发表,涉及 CRC 患者的高 PNI 与低 PNI。
本荟萃分析共纳入 10 项研究,共计 6372 例患者。我们的综合分析表明,低 PNI 组的总生存(OS)(HR=1.87,95%CI=1.45-2.42,P<0.01)、癌症特异性生存(HR=1.53,95%CI=1.07-2.19,P=0.02)和无病生存(HR=1.67,95%CI=1.23-2.26,P<0.01)均显著降低。此外,亚组结果表明,高 PNI 可作为 TNM 分期 II(HR=1.93,95%CI=1.29-2.90,P<0.01)和 III(HR=1.71,95%CI=1.25-2.34,P<0.01)期 OS 改善的显著指标,尽管在 TNM 分期 I 或 IV 期观察到类似的趋势,但无统计学意义。关于术后并发症,汇总结果表明,低 PNI 组的总并发症和严重并发症发生率显著增加。
本研究结果表明,术前 PNI 较高的 CRC 患者 OS 显著改善。然而,目前的研究几乎仅纳入亚洲 CRC 患者。